FILING CAPTION: Prohibits dispensing of certain drugs for COVID19 prevention; limits treatment to COVID19 hospitalized patients
EFFECTIVE DATE: 03/25/2020 THROUGH 09/20/2020
AGENCY APPROVED DATE: 03/25/2020
CONTACT: Rachel Melvin |
800 NE Oregon St., Suite 150 |
Filed By: |
971-673-0001 |
Portland,OR 97232 |
Rachel Melvin |
pharmacy.rulemaking@oregon.gov |
|
Rules Coordinator |
NEED FOR THE RULE(S):
On March 8, 2020 Governor Brown declared a public health emergency in Oregon related to the coronavirus pandemic (COVID-19). Whereas, during a declared emergency, the Board (or the Executive Director acting on behalf of the Board pursuant to OAR 855-007-0040) may adopt a temporary emergency rule as a way to address regulations impacting the health, safety and welfare of Oregonians. Chloroquine is effective for malaria treatment and prophylaxis, and hydroxychloroquine is effective for treatment of rheumatoid arthritis, systemic lupus erythematosus and porphyria cutanea tarda. There are no data currently available to justify the use of chloroquine or hydroxychloroquine for prevention or treatment of sub-critical COVID-19 infection. There are no data currently available on the use, dosing, or duration of these medication for COVID-19 infection. Use of these agents for the presumptive treatment or prevention of COVID-19 infection threatens the supply for patients who depend on its availability.
JUSTIFICATION OF TEMPORARY FILING:
Use of these agents for the presumptive treatment or prevention of COVID-19 infection threatens the supply for patients who depend on its availability.
DOCUMENTS RELIED UPON, AND WHERE THEY ARE AVAILABLE:
Executive Order No. 20-03 located on the Governor's website at https://govstatus.egov.com/or-covid-19